|
OMIM |
Link |
Information gain |
01 |
|
VRNI
|
[NCBI]
|
0.0179293
|
|
|
polycystic kidneys
|
[NCBI]
|
0.00147753
|
|
|
MPO
|
[NCBI]
|
0.00143512
|
|
|
sjogren syndrome
|
[NCBI]
|
0.00134777
|
|
|
CEACAM5
|
[NCBI]
|
0.001204
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00119951
|
|
|
TH
|
[NCBI]
|
0.00107291
|
|
|
KLK3
|
[NCBI]
|
0.00106221
|
|
|
BDNF
|
[NCBI]
|
0.000986248
|
|
|
ARVD5
|
[NCBI]
|
0.000911862
|
|
|
GDNF
|
[NCBI]
|
0.000899979
|
|
|
SCZD6
|
[NCBI]
|
0.000751711
|
|
|
krabbe disease
|
[NCBI]
|
0.000704148
|
|
|
HPS
|
[NCBI]
|
0.000600964
|
|
|
AFP
|
[NCBI]
|
0.00058256
|
|
|
GFAP
|
[NCBI]
|
0.000574912
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000574182
|
|
|
SOD1
|
[NCBI]
|
0.000522747
|
|
|
PRL
|
[NCBI]
|
0.000493794
|
|
|
CMD1H
|
[NCBI]
|
0.000455342
|
|
|
IBD4
|
[NCBI]
|
0.000455342
|
|
|
CMD1K
|
[NCBI]
|
0.000455342
|
|
|
CORD1
|
[NCBI]
|
0.000455342
|
|
|
MYP2
|
[NCBI]
|
0.000445838
|
|
|
TNF
|
[NCBI]
|
0.000430984
|
|
|
EGFR
|
[NCBI]
|
0.000429594
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000426303
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000426303
|
|
|
ALS1
|
[NCBI]
|
0.00040039
|
|
|
CFM1
|
[NCBI]
|
0.000375284
|
|
|
IDDM13
|
[NCBI]
|
0.000375284
|
|
|
IBD6
|
[NCBI]
|
0.000375284
|
|
|
CMD1F
|
[NCBI]
|
0.000375284
|
|
|
VEGF
|
[NCBI]
|
0.000374244
|
|
|
CHS
|
[NCBI]
|
0.000362036
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000324069
|
|
|
ARVD3
|
[NCBI]
|
0.000324069
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.000324069
|
|
|
DFN4
|
[NCBI]
|
0.000324069
|
|
|
RNASE3
|
[NCBI]
|
0.000318903
|
|
|
exstrophy of bladder
|
[NCBI]
|
0.000286552
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000280501
|
|
|
SMAX1
|
[NCBI]
|
0.000279492
|
|
|
MUC1
|
[NCBI]
|
0.000274092
|
|
|
IGAN1
|
[NCBI]
|
0.000267672
|
|
|
RTT
|
[NCBI]
|
0.000263254
|
|
|
pygmy
|
[NCBI]
|
0.000257104
|
|
|
CMD1B
|
[NCBI]
|
0.000257104
|
|
|
ARVD4
|
[NCBI]
|
0.000257104
|
|
|
HD
|
[NCBI]
|
0.000255427
|
|
|
RP
|
[NCBI]
|
0.000245927
|
|
|
metatropic dwarfism
|
[NCBI]
|
0.000232987
|
|
|
STHAG4
|
[NCBI]
|
0.000232987
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.000232987
|
|
|
EGF
|
[NCBI]
|
0.000224728
|
|
|
GUSB
|
[NCBI]
|
0.000221018
|
|
|
hurler syndrome
|
[NCBI]
|
0.000220374
|
|
|
CNTF
|
[NCBI]
|
0.00021932
|
|
|
SLC6A3
|
[NCBI]
|
0.000218733
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
0.00021266
|
|
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
0.00021266
|
|
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.00021266
|
|
|
CHAT
|
[NCBI]
|
0.00021149
|
|
|
MBP
|
[NCBI]
|
0.000206641
|
|
|
NGFB
|
[NCBI]
|
0.000199001
|
|
|
CRC
|
[NCBI]
|
0.000198164
|
|
|
G6PD
|
[NCBI]
|
0.000195533
|
|
|
PAND1
|
[NCBI]
|
0.000195166
|
|
|
SHBG
|
[NCBI]
|
0.000193124
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000180085
|
|
|
pulmonary alveolar proteinosis, acquired
|
[NCBI]
|
0.000179872
|
|
|
DWS
|
[NCBI]
|
0.000172635
|
|
|
storage pool platelet disease
|
[NCBI]
|
0.000166334
|
|
|
IBD5
|
[NCBI]
|
0.000166334
|
|
|
APS2
|
[NCBI]
|
0.000154233
|
|
|
ETL2
|
[NCBI]
|
0.000154233
|
|
|
SPP1
|
[NCBI]
|
0.000148963
|
|
|
CAT
|
[NCBI]
|
0.00014704
|
|
|
TYMS
|
[NCBI]
|
0.000136501
|
|
|
sandhoff disease
|
[NCBI]
|
0.000135097
|
|
|
DYT2
|
[NCBI]
|
0.000133433
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
0.000133433
|
|
|
SHH
|
[NCBI]
|
0.000131352
|
|
|
FMF
|
[NCBI]
|
0.000129617
|
|
|
ARSB
|
[NCBI]
|
0.0001284
|
|
|
CDK5
|
[NCBI]
|
0.000126797
|
|
|
PGR
|
[NCBI]
|
0.000122406
|
|
|
amyloidosis vi
|
[NCBI]
|
0.0001209
|
|
|
UOX
|
[NCBI]
|
0.000119799
|
|
|
CMT1A
|
[NCBI]
|
0.000116963
|
|
|
CTGF
|
[NCBI]
|
0.00011424
|
|
|
CD
|
[NCBI]
|
0.00011376
|
|
|
ASPA
|
[NCBI]
|
0.00011239
|
|
|
MFS
|
[NCBI]
|
0.000111301
|
|
|
sickle cell anemia
|
[NCBI]
|
0.000108073
|
|
|
NPC1
|
[NCBI]
|
0.000107634
|
|
|
GALC
|
[NCBI]
|
0.000107368
|
|
|
complement factor h deficiency
|
[NCBI]
|
0.000106636
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
0.000102489
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000101467
|
|
|
MAFD2
|
[NCBI]
|
0.000101467
|
|
|
PD
|
[NCBI]
|
9.8632e-05
|
|
|
HBB
|
[NCBI]
|
9.73445e-05
|
|
|
CMD1L
|
[NCBI]
|
9.34923e-05
|
|
|
NEK1
|
[NCBI]
|
9.34923e-05
|
|
|
PTH
|
[NCBI]
|
9.30901e-05
|
|
|
down syndrome
|
[NCBI]
|
9.23645e-05
|
|
|
PMD
|
[NCBI]
|
8.91412e-05
|
|
|
IPEX
|
[NCBI]
|
8.85133e-05
|
|
|
DGS
|
[NCBI]
|
8.84883e-05
|
|
|
TBX1
|
[NCBI]
|
8.42688e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
8.41441e-05
|
|
|
VDR
|
[NCBI]
|
8.09924e-05
|
|
|
RAI1
|
[NCBI]
|
7.97121e-05
|
|
|
SCA7
|
[NCBI]
|
7.95981e-05
|
|
|
ADA
|
[NCBI]
|
7.81067e-05
|
|
|
HGF
|
[NCBI]
|
7.8085e-05
|
|
|
small cell cancer of the lung
|
[NCBI]
|
7.79484e-05
|
|
|
CVID
|
[NCBI]
|
7.34571e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
7.30134e-05
|
|
|
SLC11A2
|
[NCBI]
|
7.27209e-05
|
|
|
FRAS1
|
[NCBI]
|
7.27157e-05
|
|
|
CRKL
|
[NCBI]
|
7.27157e-05
|
|
|
FMR1
|
[NCBI]
|
7.19842e-05
|
|
|
SMS
|
[NCBI]
|
7.16437e-05
|
|
|
FAAH
|
[NCBI]
|
7.08873e-05
|
|
|
ATXN7
|
[NCBI]
|
7.08765e-05
|
|
|
MKS3
|
[NCBI]
|
7.06106e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
7.0224e-05
|
|
|
ARMD1
|
[NCBI]
|
6.89972e-05
|
|
|
F2R
|
[NCBI]
|
6.88689e-05
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
6.83897e-05
|
|
|
NPY
|
[NCBI]
|
6.65921e-05
|
|
|
APCS
|
[NCBI]
|
6.52804e-05
|
|
|
BCR
|
[NCBI]
|
6.45762e-05
|
|
|
SLOS
|
[NCBI]
|
6.34042e-05
|
|
|
DNAJB1
|
[NCBI]
|
6.30991e-05
|
|
|
ADAMTS5
|
[NCBI]
|
6.30991e-05
|
|
|
fraser syndrome
|
[NCBI]
|
6.27429e-05
|
|
|
autoimmune disease
|
[NCBI]
|
6.27173e-05
|
|
|
LCA12
|
[NCBI]
|
6.20412e-05
|
|
|
NPHS3
|
[NCBI]
|
6.20412e-05
|
|
|
MKS5
|
[NCBI]
|
6.20412e-05
|
|
|
XDH
|
[NCBI]
|
6.0906e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
5.99756e-05
|
|
|
SLC18A3
|
[NCBI]
|
5.86594e-05
|
|
|
APP
|
[NCBI]
|
5.86288e-05
|
|
|
HP
|
[NCBI]
|
5.85305e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
5.84884e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 5
|
[NCBI]
|
5.79851e-05
|
|
|
RPE65
|
[NCBI]
|
5.75591e-05
|
|
|
SCN8A
|
[NCBI]
|
5.7502e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
5.39597e-05
|
|
|
SGCD
|
[NCBI]
|
5.36734e-05
|
|
|
DHFR
|
[NCBI]
|
5.36218e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
5.29503e-05
|
|
|
MAP2
|
[NCBI]
|
5.24137e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
5.08701e-05
|
|
|
IAPP
|
[NCBI]
|
5.02187e-05
|
|
|
MECP2
|
[NCBI]
|
5.0218e-05
|
|
|
ARPKD
|
[NCBI]
|
4.98444e-05
|
|
|
FGF2
|
[NCBI]
|
4.91882e-05
|
|
|
MDC1A
|
[NCBI]
|
4.89063e-05
|
|
|
SAG
|
[NCBI]
|
4.883e-05
|
|
|
ATF3
|
[NCBI]
|
4.85231e-05
|
|
|
REN
|
[NCBI]
|
4.6847e-05
|
|
|
hypertension, essential
|
[NCBI]
|
4.59054e-05
|
|
|
CLN8
|
[NCBI]
|
4.58248e-05
|
|
|
F3
|
[NCBI]
|
4.4933e-05
|
|
|
GRIP1
|
[NCBI]
|
4.45417e-05
|
|
|
SQLE
|
[NCBI]
|
4.45417e-05
|
|
|
C1ORF36
|
[NCBI]
|
4.45417e-05
|
|
|
FGF18
|
[NCBI]
|
4.45417e-05
|
|
|
PF4
|
[NCBI]
|
4.44974e-05
|
|
|
GRHL3
|
[NCBI]
|
4.41637e-05
|
|
|
ADK
|
[NCBI]
|
4.41637e-05
|
|
|
TG
|
[NCBI]
|
4.40633e-05
|
|
|
AQP4
|
[NCBI]
|
4.37052e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
4.36143e-05
|
|
|
GHRH
|
[NCBI]
|
4.35527e-05
|
|
|
UCP2
|
[NCBI]
|
4.29169e-05
|
|
|
OPLL
|
[NCBI]
|
4.27527e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
4.27527e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
4.27527e-05
|
|
|
PDV
|
[NCBI]
|
4.27527e-05
|
|
|
CALCRL
|
[NCBI]
|
4.24234e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
4.14456e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
4.14456e-05
|
|
|
TF
|
[NCBI]
|
4.11865e-05
|
|
|
FTD
|
[NCBI]
|
4.11201e-05
|
|
|
DFSP
|
[NCBI]
|
4.09457e-05
|
|
|
SCIDX1
|
[NCBI]
|
4.06999e-05
|
|
|
SIM2
|
[NCBI]
|
4.02531e-05
|
|
|
hemophilia a
|
[NCBI]
|
4.02452e-05
|
|
|
ALK
|
[NCBI]
|
4.0214e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
4.00097e-05
|
|
|
DFNA22
|
[NCBI]
|
3.99253e-05
|
|
|
CLSD
|
[NCBI]
|
3.99253e-05
|
|
|
JBTS7
|
[NCBI]
|
3.99253e-05
|
|
|
OPTB6
|
[NCBI]
|
3.99253e-05
|
|
|
GIST
|
[NCBI]
|
3.97899e-05
|
|
|
TPO
|
[NCBI]
|
3.97163e-05
|
|
|
TLR2
|
[NCBI]
|
3.91761e-05
|
|
|
alkaptonuria
|
[NCBI]
|
3.90598e-05
|
|
|
LPL
|
[NCBI]
|
3.9009e-05
|
|
|
AR
|
[NCBI]
|
3.7968e-05
|
|
|
AN2
|
[NCBI]
|
3.76698e-05
|
|
|
STGD3
|
[NCBI]
|
3.75381e-05
|
|
|
CTSK
|
[NCBI]
|
3.7369e-05
|
|
|
WAS
|
[NCBI]
|
3.72579e-05
|
|
|
SLC1A1
|
[NCBI]
|
3.69003e-05
|
|
|
NSF
|
[NCBI]
|
3.69003e-05
|
|
|
CLN3
|
[NCBI]
|
3.67155e-05
|
|
|
CJD
|
[NCBI]
|
3.67057e-05
|
|
|
SFRP2
|
[NCBI]
|
3.63873e-05
|
|
|
CTF1
|
[NCBI]
|
3.63873e-05
|
|
|
F2RL3
|
[NCBI]
|
3.63873e-05
|
|
|
CNR2
|
[NCBI]
|
3.63873e-05
|
|
|
PTK2
|
[NCBI]
|
3.63008e-05
|
|
|
GJA1
|
[NCBI]
|
3.58133e-05
|
|
|
AVP
|
[NCBI]
|
3.56961e-05
|
|
|
CSTB
|
[NCBI]
|
3.54314e-05
|
|
|
CXCL12
|
[NCBI]
|
3.53712e-05
|
|
|
WS2A
|
[NCBI]
|
3.52941e-05
|
|
|
LAD
|
[NCBI]
|
3.50893e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.50893e-05
|
|
|
CHM
|
[NCBI]
|
3.48838e-05
|
|
|
NPC1
|
[NCBI]
|
3.40098e-05
|
|
|
PLN
|
[NCBI]
|
3.40098e-05
|
|
|
CNR1
|
[NCBI]
|
3.39767e-05
|
|
|
SEMA3A
|
[NCBI]
|
3.39767e-05
|
|
|
FCHL
|
[NCBI]
|
3.38756e-05
|
|
|
MG
|
[NCBI]
|
3.3505e-05
|
|
|
DSMA1
|
[NCBI]
|
3.32436e-05
|
|
|
FGF7
|
[NCBI]
|
3.27949e-05
|
|
|
CDSP
|
[NCBI]
|
3.27111e-05
|
|
|
ABCC1
|
[NCBI]
|
3.2611e-05
|
|
|
SMA1
|
[NCBI]
|
3.24531e-05
|
|
|
PDCD8
|
[NCBI]
|
3.18489e-05
|
|
|
CMD1J
|
[NCBI]
|
3.17998e-05
|
|
|
hydrops fetalis, idiopathic
|
[NCBI]
|
3.17998e-05
|
|
|
diaphragmatic hernia 3
|
[NCBI]
|
3.17998e-05
|
|
|
proopiomelanocortin deficiency
|
[NCBI]
|
3.17998e-05
|
|
|
CSNBAD2
|
[NCBI]
|
3.17998e-05
|
|
|
ichthyosis hystrix gravior
|
[NCBI]
|
3.17998e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
3.17998e-05
|
|
|
CMD1P
|
[NCBI]
|
3.17998e-05
|
|
|
LCA10
|
[NCBI]
|
3.17998e-05
|
|
|
zinc in breast milk, reduced
|
[NCBI]
|
3.17998e-05
|
|
|
PVR
|
[NCBI]
|
3.17797e-05
|
|
|
STX12
|
[NCBI]
|
3.15487e-05
|
|
|
HERC2
|
[NCBI]
|
3.15487e-05
|
|
|
CADPS2
|
[NCBI]
|
3.15487e-05
|
|
|
MCOLN2
|
[NCBI]
|
3.15487e-05
|
|
|
TNFSF18
|
[NCBI]
|
3.15487e-05
|
|
|
CDV1
|
[NCBI]
|
3.15487e-05
|
|
|
NDE1
|
[NCBI]
|
3.15487e-05
|
|
|
ATP5C1
|
[NCBI]
|
3.15487e-05
|
|
|
VAMP1
|
[NCBI]
|
3.15487e-05
|
|
|
DDAH1
|
[NCBI]
|
3.15487e-05
|
|
|
TGFBR3
|
[NCBI]
|
3.15487e-05
|
|
|
SYVN1
|
[NCBI]
|
3.15487e-05
|
|
|
LY96
|
[NCBI]
|
3.15487e-05
|
|
|
TXNRD2
|
[NCBI]
|
3.15487e-05
|
|
|
ZIC4
|
[NCBI]
|
3.15487e-05
|
|
|
PKN3
|
[NCBI]
|
3.15487e-05
|
|
|
AKT1S1
|
[NCBI]
|
3.15487e-05
|
|
|
HPS5
|
[NCBI]
|
3.15487e-05
|
|
|
JRKL
|
[NCBI]
|
3.15487e-05
|
|
|
DCTN2
|
[NCBI]
|
3.15487e-05
|
|
|
TBX18
|
[NCBI]
|
3.15487e-05
|
|
|
ATG4C
|
[NCBI]
|
3.15487e-05
|
|
|
HPS6
|
[NCBI]
|
3.15487e-05
|
|
|
SPATS2
|
[NCBI]
|
3.15487e-05
|
|
|
ARMETL1
|
[NCBI]
|
3.15487e-05
|
|
|
SLC16A7
|
[NCBI]
|
3.15487e-05
|
|
|
ANGPTL3
|
[NCBI]
|
3.15487e-05
|
|
|
MUTED
|
[NCBI]
|
3.15487e-05
|
|
|
DNAL4
|
[NCBI]
|
3.15487e-05
|
|
|
TMOD2
|
[NCBI]
|
3.15487e-05
|
|
|
LR8
|
[NCBI]
|
3.15487e-05
|
|
|
CD300A
|
[NCBI]
|
3.15487e-05
|
|
|
PLCE1
|
[NCBI]
|
3.15487e-05
|
|
|
SLC6A5
|
[NCBI]
|
3.15487e-05
|
|
|
ADAMTS2
|
[NCBI]
|
3.15487e-05
|
|
|
SGIP1
|
[NCBI]
|
3.15487e-05
|
|
|
PTPRQ
|
[NCBI]
|
3.15487e-05
|
|
|
transmembrane protein 90a
|
[NCBI]
|
3.15487e-05
|
|
|
S100A6
|
[NCBI]
|
3.15487e-05
|
|
|
PDHA2
|
[NCBI]
|
3.15487e-05
|
|
|
DNAJC7
|
[NCBI]
|
3.15487e-05
|
|
|
C3AR1
|
[NCBI]
|
3.15487e-05
|
|
|
PDCD1LG2
|
[NCBI]
|
3.15487e-05
|
|
|
PRKG1
|
[NCBI]
|
3.15487e-05
|
|
|
CACNA1E
|
[NCBI]
|
3.15487e-05
|
|
|
UQCRC2
|
[NCBI]
|
3.15487e-05
|
|
|
MAPK8IP3
|
[NCBI]
|
3.15487e-05
|
|
|
B4GALNT1
|
[NCBI]
|
3.15487e-05
|
|
|
FREM1
|
[NCBI]
|
3.15487e-05
|
|
|
PPP3CC
|
[NCBI]
|
3.15487e-05
|
|
|
RC3H1
|
[NCBI]
|
3.15487e-05
|
|
|
DLGAP3
|
[NCBI]
|
3.15487e-05
|
|
|
intimal thickness-related receptor
|
[NCBI]
|
3.15487e-05
|
|
|
MAN2B1
|
[NCBI]
|
3.13941e-05
|
|
|
MOG
|
[NCBI]
|
3.13941e-05
|
|
|
GNRH1
|
[NCBI]
|
3.13848e-05
|
|
|
wilson disease
|
[NCBI]
|
3.13733e-05
|
|
|
PDE6B
|
[NCBI]
|
3.13608e-05
|
|
|
PI
|
[NCBI]
|
3.12295e-05
|
|
|
SRS
|
[NCBI]
|
3.11502e-05
|
|
|
INDO
|
[NCBI]
|
3.09226e-05
|
|
|
TERF2
|
[NCBI]
|
3.09226e-05
|
|
|
FSTL1
|
[NCBI]
|
3.09226e-05
|
|
|
WBS
|
[NCBI]
|
3.07739e-05
|
|
|
IHH
|
[NCBI]
|
3.06897e-05
|
|
|
PPARA
|
[NCBI]
|
3.05567e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
3.05179e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
3.04006e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
2.99382e-05
|
|
|
TLR4
|
[NCBI]
|
2.98036e-05
|
|
|
PAX6
|
[NCBI]
|
2.93405e-05
|
|
|
NIDDM
|
[NCBI]
|
2.91857e-05
|
|
|
WS1
|
[NCBI]
|
2.91857e-05
|
|
|
AP3B1
|
[NCBI]
|
2.90888e-05
|
|
|
UCHL1
|
[NCBI]
|
2.90888e-05
|
|
|
PIK3CG
|
[NCBI]
|
2.90888e-05
|
|
|
RELN
|
[NCBI]
|
2.90888e-05
|
|
|
GLB1
|
[NCBI]
|
2.89425e-05
|
|
|
HEMB
|
[NCBI]
|
2.85982e-05
|
|
|
IL2
|
[NCBI]
|
2.8577e-05
|
|
|
MAP3K5
|
[NCBI]
|
2.85209e-05
|
|
|
IDE
|
[NCBI]
|
2.85209e-05
|
|
|
POAG
|
[NCBI]
|
2.84887e-05
|
|
|
DMPK
|
[NCBI]
|
2.82915e-05
|
|
|
TFF3
|
[NCBI]
|
2.82915e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
2.80097e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
2.80097e-05
|
|
|
SRF
|
[NCBI]
|
2.77716e-05
|
|
|
IFNA1
|
[NCBI]
|
2.7752e-05
|
|
|
fabry disease
|
[NCBI]
|
2.72712e-05
|
|
|
C5
|
[NCBI]
|
2.70139e-05
|
|
|
HMOX1
|
[NCBI]
|
2.70139e-05
|
|
|
MPV17
|
[NCBI]
|
2.68341e-05
|
|
|
GPR98
|
[NCBI]
|
2.68341e-05
|
|
|
AGRP
|
[NCBI]
|
2.68341e-05
|
|
|
IGAD2
|
[NCBI]
|
2.66482e-05
|
|
|
glomerulonephritis with sparse hair and telangiectases
|
[NCBI]
|
2.66482e-05
|
|
|
CMD1G
|
[NCBI]
|
2.66482e-05
|
|
|
oroacral syndrome, verloes-koulischer type
|
[NCBI]
|
2.66482e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
2.66482e-05
|
|
|
ATCAY
|
[NCBI]
|
2.66482e-05
|
|
|
dermatitis herpetiformis, familial
|
[NCBI]
|
2.66482e-05
|
|
|
PEDF
|
[NCBI]
|
2.65661e-05
|
|
|
omenn syndrome
|
[NCBI]
|
2.65111e-05
|
|
|
AQP2
|
[NCBI]
|
2.64857e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.64102e-05
|
|
|
BRCA2
|
[NCBI]
|
2.602e-05
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
2.59315e-05
|
|
|
BMP2
|
[NCBI]
|
2.58585e-05
|
|
|
SOX10
|
[NCBI]
|
2.58585e-05
|
|
|
LIP
|
[NCBI]
|
2.57148e-05
|
|
|
HFE
|
[NCBI]
|
2.54956e-05
|
|
|
GHR
|
[NCBI]
|
2.53317e-05
|
|
|
NHS
|
[NCBI]
|
2.51131e-05
|
|
|
hartnup disorder
|
[NCBI]
|
2.51131e-05
|
|
|
AIS
|
[NCBI]
|
2.50795e-05
|
|
|
LNS
|
[NCBI]
|
2.50421e-05
|
|
|
ADM
|
[NCBI]
|
2.48272e-05
|
|
|
MBL2
|
[NCBI]
|
2.42899e-05
|
|
|
ATS
|
[NCBI]
|
2.40247e-05
|
|
|
PEE1
|
[NCBI]
|
2.40115e-05
|
|
|
APOB
|
[NCBI]
|
2.38749e-05
|
|
|
GJB2
|
[NCBI]
|
2.36874e-05
|
|
|
ACCN3
|
[NCBI]
|
2.35928e-05
|
|
|
LAMB2
|
[NCBI]
|
2.35928e-05
|
|
|
SLC39A4
|
[NCBI]
|
2.35928e-05
|
|
|
FGF4
|
[NCBI]
|
2.35928e-05
|
|
|
CAST
|
[NCBI]
|
2.35928e-05
|
|
|
MBNL1
|
[NCBI]
|
2.35928e-05
|
|
|
TGM2
|
[NCBI]
|
2.35928e-05
|
|
|
BCNS
|
[NCBI]
|
2.32297e-05
|
|
|
IDDM12
|
[NCBI]
|
2.2909e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
2.2909e-05
|
|
|
DFNA13
|
[NCBI]
|
2.2909e-05
|
|
|
CMD1D
|
[NCBI]
|
2.2909e-05
|
|
|
DFNB6
|
[NCBI]
|
2.2909e-05
|
|
|
SLE
|
[NCBI]
|
2.255e-05
|
|
|
AGER
|
[NCBI]
|
2.2543e-05
|
|
|
GCPS
|
[NCBI]
|
2.24478e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
2.23403e-05
|
|
|
GCDH
|
[NCBI]
|
2.22469e-05
|
|
|
TRPV1
|
[NCBI]
|
2.22469e-05
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
2.2198e-05
|
|
|
SPINK1
|
[NCBI]
|
2.2192e-05
|
|
|
FSHMD1A
|
[NCBI]
|
2.20425e-05
|
|
|
NTRK2
|
[NCBI]
|
2.18481e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.16661e-05
|
|
|
argininemia
|
[NCBI]
|
2.14261e-05
|
|
|
GIP
|
[NCBI]
|
2.09965e-05
|
|
|
ARG1
|
[NCBI]
|
2.09282e-05
|
|
|
RTN4
|
[NCBI]
|
2.09282e-05
|
|
|
F2RL1
|
[NCBI]
|
2.09282e-05
|
|
|
PTPRO
|
[NCBI]
|
2.09282e-05
|
|
|
TFF2
|
[NCBI]
|
2.09282e-05
|
|
|
KCNJ1
|
[NCBI]
|
2.09282e-05
|
|
|
AIPL1
|
[NCBI]
|
2.09282e-05
|
|
|
PSACH
|
[NCBI]
|
2.09033e-05
|
|
|
TP53
|
[NCBI]
|
2.04974e-05
|
|
|
autism
|
[NCBI]
|
2.04854e-05
|
|
|
NF1
|
[NCBI]
|
2.034e-05
|
|
|
SNCA
|
[NCBI]
|
2.02014e-05
|
|
|
HCRT
|
[NCBI]
|
2.01443e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
2.00016e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
2.00016e-05
|
|
|
MRXSL
|
[NCBI]
|
2.00016e-05
|
|
|
RCDP2
|
[NCBI]
|
2.00016e-05
|
|
|
ARVD2
|
[NCBI]
|
2.00016e-05
|
|
|
LCA2
|
[NCBI]
|
2.00016e-05
|
|
|
OCD1
|
[NCBI]
|
2.00016e-05
|
|
|
anemia, microcytic
|
[NCBI]
|
2.00016e-05
|
|
|
HGPS
|
[NCBI]
|
1.98391e-05
|
|
|
ALD
|
[NCBI]
|
1.96638e-05
|
|
|
HSCR1
|
[NCBI]
|
1.96517e-05
|
|
|
PXE
|
[NCBI]
|
1.93705e-05
|
|
|
IBD1
|
[NCBI]
|
1.9325e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
1.93165e-05
|
|
|
AMH
|
[NCBI]
|
1.92649e-05
|
|
|
EIG
|
[NCBI]
|
1.91091e-05
|
|
|
KDR
|
[NCBI]
|
1.89749e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.89422e-05
|
|
|
ADHD
|
[NCBI]
|
1.89373e-05
|
|
|
RAG2
|
[NCBI]
|
1.86822e-05
|
|
|
C5R1
|
[NCBI]
|
1.86822e-05
|
|
|
DYRK1A
|
[NCBI]
|
1.86822e-05
|
|
|
PRKAG2
|
[NCBI]
|
1.86822e-05
|
|
|
TTC10
|
[NCBI]
|
1.86822e-05
|
|
|
MAPK7
|
[NCBI]
|
1.86822e-05
|
|
|
MERTK
|
[NCBI]
|
1.86822e-05
|
|
|
TS
|
[NCBI]
|
1.86621e-05
|
|
|
PON1
|
[NCBI]
|
1.86144e-05
|
|
|
KSS
|
[NCBI]
|
1.86056e-05
|
|
|
CMH
|
[NCBI]
|
1.83549e-05
|
|
|
AEZ
|
[NCBI]
|
1.83489e-05
|
|
|
NEK8
|
[NCBI]
|
1.81929e-05
|
|
|
EIF2C1
|
[NCBI]
|
1.81929e-05
|
|
|
CCT4
|
[NCBI]
|
1.81929e-05
|
|
|
SLC6A9
|
[NCBI]
|
1.81929e-05
|
|
|
TMIE
|
[NCBI]
|
1.81929e-05
|
|
|
scribble, drosophila, homolog of
|
[NCBI]
|
1.81929e-05
|
|
|
MIRN133A2
|
[NCBI]
|
1.81929e-05
|
|
|
SPTBN2
|
[NCBI]
|
1.81929e-05
|
|
|
NUCB1
|
[NCBI]
|
1.81929e-05
|
|
|
SH2D2A
|
[NCBI]
|
1.81929e-05
|
|
|
G6PC3
|
[NCBI]
|
1.81929e-05
|
|
|
NAP1L2
|
[NCBI]
|
1.81929e-05
|
|
|
CDON
|
[NCBI]
|
1.81929e-05
|
|
|
RORC
|
[NCBI]
|
1.81929e-05
|
|
|
CXCR7
|
[NCBI]
|
1.81929e-05
|
|
|
MC5R
|
[NCBI]
|
1.81929e-05
|
|
|
BCAT2
|
[NCBI]
|
1.81929e-05
|
|
|
MGEA5
|
[NCBI]
|
1.81929e-05
|
|
|
NDUFA1
|
[NCBI]
|
1.81929e-05
|
|
|
MIRN92-1
|
[NCBI]
|
1.81929e-05
|
|
|
ACADL
|
[NCBI]
|
1.81929e-05
|
|
|
ZIC1
|
[NCBI]
|
1.81929e-05
|
|
|
MCOLN3
|
[NCBI]
|
1.81929e-05
|
|
|
NPPC
|
[NCBI]
|
1.81929e-05
|
|
|
MIRN17
|
[NCBI]
|
1.81929e-05
|
|
|
CACNA2D2
|
[NCBI]
|
1.81929e-05
|
|
|
TMEM49
|
[NCBI]
|
1.81929e-05
|
|
|
F2RL2
|
[NCBI]
|
1.81929e-05
|
|
|
PDE5A
|
[NCBI]
|
1.81929e-05
|
|
|
PIK3R2
|
[NCBI]
|
1.81929e-05
|
|
|
SRPR
|
[NCBI]
|
1.81929e-05
|
|
|
P2RX4
|
[NCBI]
|
1.81929e-05
|
|
|
MAN2A1
|
[NCBI]
|
1.81929e-05
|
|
|
F8A
|
[NCBI]
|
1.81929e-05
|
|
|
SLC39A7
|
[NCBI]
|
1.81929e-05
|
|
|
ERVWE1
|
[NCBI]
|
1.81929e-05
|
|
|
RPGRIP1L
|
[NCBI]
|
1.81929e-05
|
|
|
HLA-DRB5
|
[NCBI]
|
1.81929e-05
|
|
|
MIRN133A1
|
[NCBI]
|
1.81929e-05
|
|
|
hepatocellular carcinoma-associated antigen 112
|
[NCBI]
|
1.81929e-05
|
|
|
UPP1
|
[NCBI]
|
1.81929e-05
|
|
|
CNO
|
[NCBI]
|
1.81929e-05
|
|
|
fc receptor homolog expressed in b cells
|
[NCBI]
|
1.81929e-05
|
|
|
HOXB8
|
[NCBI]
|
1.81929e-05
|
|
|
FGL2
|
[NCBI]
|
1.81929e-05
|
|
|
CCNG1
|
[NCBI]
|
1.81929e-05
|
|
|
DEF6
|
[NCBI]
|
1.81929e-05
|
|
|
SIRT2
|
[NCBI]
|
1.81929e-05
|
|
|
SEC23A
|
[NCBI]
|
1.81929e-05
|
|
|
MAP6
|
[NCBI]
|
1.81929e-05
|
|
|
KLF15
|
[NCBI]
|
1.81929e-05
|
|
|
SPRR2A
|
[NCBI]
|
1.81929e-05
|
|
|
EEF1A2
|
[NCBI]
|
1.81929e-05
|
|
|
SLC30A3
|
[NCBI]
|
1.81929e-05
|
|
|
PPP3R1
|
[NCBI]
|
1.81929e-05
|
|
|
MMP2
|
[NCBI]
|
1.79718e-05
|
|
|
G6PC2
|
[NCBI]
|
1.78323e-05
|
|
|
CMD1E
|
[NCBI]
|
1.7644e-05
|
|
|
SPMM
|
[NCBI]
|
1.7644e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
1.7644e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
1.7644e-05
|
|
|
OPTB5
|
[NCBI]
|
1.7644e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
1.7644e-05
|
|
|
IDDM5
|
[NCBI]
|
1.7644e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
1.7644e-05
|
|
|
ovarian cancer, epithelial
|
[NCBI]
|
1.7644e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
1.7644e-05
|
|
|
neural tube defects
|
[NCBI]
|
1.74333e-05
|
|
|
HDC
|
[NCBI]
|
1.71833e-05
|
|
|
DM2
|
[NCBI]
|
1.70873e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
1.70873e-05
|
|
|
PSORS1
|
[NCBI]
|
1.69216e-05
|
|
|
IL23A
|
[NCBI]
|
1.67545e-05
|
|
|
GALK1
|
[NCBI]
|
1.67545e-05
|
|
|
TPM3
|
[NCBI]
|
1.67545e-05
|
|
|
DCTN1
|
[NCBI]
|
1.67545e-05
|
|
|
ZIC3
|
[NCBI]
|
1.67545e-05
|
|
|
RPGRIP1
|
[NCBI]
|
1.67545e-05
|
|
|
RELA
|
[NCBI]
|
1.67545e-05
|
|
|
ACE
|
[NCBI]
|
1.67156e-05
|
|
|
BTK
|
[NCBI]
|
1.66688e-05
|
|
|
ETM1
|
[NCBI]
|
1.65658e-05
|
|
|
OPTB1
|
[NCBI]
|
1.65658e-05
|
|
|
TNC
|
[NCBI]
|
1.60288e-05
|
|
|
MITF
|
[NCBI]
|
1.59071e-05
|
|
|
CGL2
|
[NCBI]
|
1.57429e-05
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
1.57429e-05
|
|
|
PHEX
|
[NCBI]
|
1.57257e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
1.5677e-05
|
|
|
CLN6
|
[NCBI]
|
1.5677e-05
|
|
|
ODG2
|
[NCBI]
|
1.5677e-05
|
|
|
tracheoesophageal fistula with or without esophageal atresia
|
[NCBI]
|
1.5677e-05
|
|
|
elejalde disease
|
[NCBI]
|
1.5677e-05
|
|
|
SLEB1
|
[NCBI]
|
1.5677e-05
|
|
|
SCA8
|
[NCBI]
|
1.5677e-05
|
|
|
AD
|
[NCBI]
|
1.56732e-05
|
|
|
PTGS2
|
[NCBI]
|
1.54591e-05
|
|
|
SOD2
|
[NCBI]
|
1.51421e-05
|
|
|
ENAM
|
[NCBI]
|
1.50768e-05
|
|
|
HCRTR2
|
[NCBI]
|
1.50768e-05
|
|
|
GPR24
|
[NCBI]
|
1.50768e-05
|
|
|
PRNP
|
[NCBI]
|
1.50429e-05
|
|
|
OPRM1
|
[NCBI]
|
1.49621e-05
|
|
|
TFR2
|
[NCBI]
|
1.49621e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
1.49613e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.49563e-05
|
|
|
DSG3
|
[NCBI]
|
1.49288e-05
|
|
|
menkes disease
|
[NCBI]
|
1.47723e-05
|
|
|
PTHR1
|
[NCBI]
|
1.46165e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.45919e-05
|
|
|
AS
|
[NCBI]
|
1.45214e-05
|
|
|
OSM
|
[NCBI]
|
1.44498e-05
|
|
|
ACADM
|
[NCBI]
|
1.44491e-05
|
|
|
LOX
|
[NCBI]
|
1.4233e-05
|
|
|
PRPH2
|
[NCBI]
|
1.4233e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.42184e-05
|
|
|
MYH7
|
[NCBI]
|
1.40919e-05
|
|
|
DRPLA
|
[NCBI]
|
1.40912e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
1.40021e-05
|
|
|
RP12
|
[NCBI]
|
1.40021e-05
|
|
|
atransferrinemia
|
[NCBI]
|
1.40021e-05
|
|
|
naxos disease
|
[NCBI]
|
1.40021e-05
|
|
|
CDG2A
|
[NCBI]
|
1.40021e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
1.40021e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.40021e-05
|
|
|
MODY2
|
[NCBI]
|
1.40021e-05
|
|
|
NPHP3
|
[NCBI]
|
1.40021e-05
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
1.40021e-05
|
|
|
MS
|
[NCBI]
|
1.39919e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.3826e-05
|
|
|
SLPI
|
[NCBI]
|
1.3826e-05
|
|
|
LDLR
|
[NCBI]
|
1.37196e-05
|
|
|
MAPK8
|
[NCBI]
|
1.3601e-05
|
|
|
TXNIP
|
[NCBI]
|
1.3601e-05
|
|
|
HPS1
|
[NCBI]
|
1.3601e-05
|
|
|
HEPH
|
[NCBI]
|
1.3601e-05
|
|
|
GAL3ST1
|
[NCBI]
|
1.3601e-05
|
|
|
HMGB1
|
[NCBI]
|
1.35364e-05
|
|
|
ITGB2
|
[NCBI]
|
1.35364e-05
|
|
|
ATP7A
|
[NCBI]
|
1.35364e-05
|
|
|
OPA1
|
[NCBI]
|
1.35116e-05
|
|
|
RET
|
[NCBI]
|
1.3445e-05
|
|
|
CORT
|
[NCBI]
|
1.34164e-05
|
|
|
PRKCB1
|
[NCBI]
|
1.34164e-05
|
|
|
NSEP1
|
[NCBI]
|
1.34164e-05
|
|
|
MMP20
|
[NCBI]
|
1.34164e-05
|
|
|
ID4
|
[NCBI]
|
1.34164e-05
|
|
|
PDE10A
|
[NCBI]
|
1.34164e-05
|
|
|
HTR1A
|
[NCBI]
|
1.34164e-05
|
|
|
NLGN3
|
[NCBI]
|
1.34164e-05
|
|
|
JARID2
|
[NCBI]
|
1.34164e-05
|
|
|
MAP1A
|
[NCBI]
|
1.34164e-05
|
|
|
VAV3
|
[NCBI]
|
1.34164e-05
|
|
|
DND1
|
[NCBI]
|
1.34164e-05
|
|
|
CRELD1
|
[NCBI]
|
1.34164e-05
|
|
|
RGS4
|
[NCBI]
|
1.34164e-05
|
|
|
ERN1
|
[NCBI]
|
1.34164e-05
|
|
|
MDM4
|
[NCBI]
|
1.34164e-05
|
|
|
FCGRT
|
[NCBI]
|
1.34164e-05
|
|
|
CTSH
|
[NCBI]
|
1.34164e-05
|
|
|
CD55
|
[NCBI]
|
1.34164e-05
|
|
|
PROX1
|
[NCBI]
|
1.34164e-05
|
|
|
DIDO1
|
[NCBI]
|
1.34164e-05
|
|
|
fshd gene 2
|
[NCBI]
|
1.34164e-05
|
|
|
FREM2
|
[NCBI]
|
1.34164e-05
|
|
|
PAX4
|
[NCBI]
|
1.34164e-05
|
|
|
B4GALNT2
|
[NCBI]
|
1.34164e-05
|
|
|
KY
|
[NCBI]
|
1.34164e-05
|
|
|
RETNLB
|
[NCBI]
|
1.34164e-05
|
|
|
FUT3
|
[NCBI]
|
1.34164e-05
|
|
|
SUV39H1
|
[NCBI]
|
1.34164e-05
|
|
|
HRH1
|
[NCBI]
|
1.34164e-05
|
|
|
CD19
|
[NCBI]
|
1.34164e-05
|
|
|
caytaxin
|
[NCBI]
|
1.34164e-05
|
|
|
RAB1
|
[NCBI]
|
1.34164e-05
|
|
|
GDF6
|
[NCBI]
|
1.34164e-05
|
|
|
MLP
|
[NCBI]
|
1.34164e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.34164e-05
|
|
|
NPR1
|
[NCBI]
|
1.34164e-05
|
|
|
SMPD3
|
[NCBI]
|
1.34164e-05
|
|
|
BMP3
|
[NCBI]
|
1.34164e-05
|
|
|
HTR2B
|
[NCBI]
|
1.34164e-05
|
|
|
NRTN
|
[NCBI]
|
1.34164e-05
|
|
|
TNFRSF18
|
[NCBI]
|
1.34164e-05
|
|
|
L2HGDH
|
[NCBI]
|
1.34164e-05
|
|
|
PEX5
|
[NCBI]
|
1.34164e-05
|
|
|
UCHL3
|
[NCBI]
|
1.34164e-05
|
|
|
TNFRSF4
|
[NCBI]
|
1.34164e-05
|
|
|
BGLAP
|
[NCBI]
|
1.29178e-05
|
|
|
MHS1
|
[NCBI]
|
1.2916e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.2904e-05
|
|
|
HEXA
|
[NCBI]
|
1.29013e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.29013e-05
|
|
|
JAK3
|
[NCBI]
|
1.28707e-05
|
|
|
JMML
|
[NCBI]
|
1.2848e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
1.28386e-05
|
|
|
MCOPS7
|
[NCBI]
|
1.28386e-05
|
|
|
ATXN1
|
[NCBI]
|
1.28097e-05
|
|
|
TLR5
|
[NCBI]
|
1.28097e-05
|
|
|
IRS2
|
[NCBI]
|
1.28097e-05
|
|
|
VHL
|
[NCBI]
|
1.28065e-05
|
|
|
MB
|
[NCBI]
|
1.26562e-05
|
|
|
CASR
|
[NCBI]
|
1.26562e-05
|
|
|
PKD3
|
[NCBI]
|
1.25539e-05
|
|
|
LGMD2E
|
[NCBI]
|
1.25539e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
1.25539e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
1.25539e-05
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
1.25539e-05
|
|
|
GS1
|
[NCBI]
|
1.25539e-05
|
|
|
coloboma, ocular
|
|